Style | Citing Format |
---|---|
MLA | Sharifi M, Moridnia A. "Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer." Cancer Gene Therapy, vol. 24, no. 2, 2017, pp. 75-82. |
APA | Sharifi M, Moridnia A (2017). Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer. Cancer Gene Therapy, 24(2), 75-82. |
Chicago | Sharifi M, Moridnia A. "Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer." Cancer Gene Therapy 24, no. 2 (2017): 75-82. |
Harvard | Sharifi M, Moridnia A (2017) 'Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer', Cancer Gene Therapy, 24(2), pp. 75-82. |
Vancouver | Sharifi M, Moridnia A. Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer. Cancer Gene Therapy. 2017;24(2):75-82. |
BibTex | @article{ author = {Sharifi M and Moridnia A}, title = {Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer}, journal = {Cancer Gene Therapy}, volume = {24}, number = {2}, pages = {75-82}, year = {2017} } |
RIS | TY - JOUR AU - Sharifi M AU - Moridnia A TI - Apoptosis-Inducing and Antiproliferative Effect by Inhibition of Mir-182-5P Through the Regulation of Casp9 Expression in Human Breast Cancer JO - Cancer Gene Therapy VL - 24 IS - 2 SP - 75 EP - 82 PY - 2017 ER - |